Feature|Articles|October 8, 2023
- Pharmaceutical Executive: October 2023
- Volume 43
- Issue 10
Pharmaceutical Executive, October 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive October 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 2 years ago
A Blueprint for Balanceover 2 years ago
Biopharma Stock Check: Market Review and Outlookover 2 years ago
Securing the Safety Net in Drug Access and Supportover 2 years ago
Obesity Drugs in the Payer Market: What to Expectover 2 years ago
Boosting Clinical Trials and Patient Access with Payer Insightsover 2 years ago
Are We Close to a Peak in Interest Rates?over 2 years ago
The Harms of ‘Helicopter Research’ in the Life Sciencesover 2 years ago
The Rising Importance of Patient Advocacy Innovations in Asiaover 2 years ago
A Fond FarewellNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
From Evidence to Access: How Real-World Data Delivers for Patients
2
WHO Finalizes United States’ Withdrawal from Organization: Report
3
Pharma Companies Raise List Prices, Including 16 That Had Agreements to Lower Prices with Trump Administration: Report
4
Tariff Uncertainty Drives Short-Term Manufacturing Surge as Global Pharmaceuticals Enter Fragmented Growth Phase: Report
5